CUREVERSE was founded by experts in small molecule drug discovery, brain disease therapeutics, and medicinal chemistry, who united with the shared goal of developing novel treatments for intractable brain disorders.
Biotech finance/strategy Professional
Joonbeom Park
Sr.Director / CFO
Corporate Finance and IPO Strategy
Biotech Capital Raising
B.S., Seoul National University
M.S., Korea Advanced Institute of Science and Technology (KAIST)